PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Prenn C et al. CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine. 2008 Pharmacology pmid:18212515
Jin YR et al. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. 2008 J. Cardiovasc. Pharmacol. pmid:18209568
Taketa K et al. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages. 2008 J. Biol. Chem. pmid:18208815
Kerr BJ et al. The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury. 2008 Glia pmid:18205174
Kim EH et al. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. 2008 Carcinogenesis pmid:18192694
Feltenmark S et al. Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18184802
Zhao H et al. Met-Arg-Trp derived from Rubisco lowers blood pressure via prostaglandin D(2)-dependent vasorelaxation in spontaneously hypertensive rats. 2008 Peptides pmid:18180074
Torres D et al. Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma. 2008 J. Immunol. pmid:18178816
Khan AH et al. Effect of femto to nano molar concentrations of prostaglandin analogues on pregnant rat uterine contractility. 2008 Eur. J. Pharmacol. pmid:18177857
Kuesap J et al. Prostaglandin D2 induces heme oxygenase-1 in human retinal pigment epithelial cells. 2008 Biochem. Biophys. Res. Commun. pmid:18174022
Yoon EK et al. ERK-1/-2 and p38 kinase oppositely regulate 15-deoxy-delta(12,14)-prostaglandinJ(2)-Induced PPAR-gamma activation that mediates dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. 2007 J. Korean Med. Sci. pmid:18162716
Choi IK et al. PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo. 2008 Invest New Drugs pmid:18161004
Shikada K et al. NIP-121 and cromakalim, potassium channel openers, preferentially suppress prostanoid-induced contraction of the guinea-pig isolated trachea. 1991 Eur. J. Pharmacol. pmid:1814761
Kobayashi Y et al. Syntheses of 2,6-dideoxy-6-fluoro-2-[(3R and 3S)-3- hydroxytetradecanamido]-3-O-[(3R)-3-(tetradecanoyloxy)tetra decanoyl]-D- glucopyranose 4-(dihydrogen phosphate) and 2-deoxy-2-[(3R and 3S)-3- hydroxytetradecanamido]-3-O-[(3R)-3-(tetradecanoyloxy)tetra decanoyl]- alpha-D-glucopyranosyl fluoride 4-(dihydrogen phosphate): fluorosugar analogues of GLA-60. 1991 Carbohydr. Res. pmid:1813114
Napimoga MH et al. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway. 2008 J. Immunol. pmid:18097063
Shiraishi Y et al. Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. 2008 J. Immunol. pmid:18097056
Haworth O and Buckley CD Resolving the problem of persistence in the switch from acute to chronic inflammation. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:18093938
Kuboki S et al. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. 2008 Hepatology pmid:18085707
García-Bueno B et al. Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. 2008 Endocrinology pmid:18079203
Rajakariar R et al. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:18077391
Ferreira-Silva V et al. Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma. 2008 Eur. J. Pharmacol. pmid:18054911
Uchida K and Shibata T 15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses. 2008 Chem. Res. Toxicol. pmid:18052108
Tanaka H et al. [Synthesis of chemical probes based on combinatorial chemistry and lab automation]. 2007 Tanpakushitsu Kakusan Koso pmid:18051395
Zhang J et al. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts. 2008 Clin. Exp. Pharmacol. Physiol. pmid:18047631
Brugger N et al. Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species. 2008 J Sex Med pmid:18047485
Yokoi H et al. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. 2008 J. Allergy Clin. Immunol. pmid:18036650
Yu JH et al. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas. 2008 Int. J. Biochem. Cell Biol. pmid:18035585
Kim WJ et al. Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. 2007 EMBO J. pmid:18034160
Grill M et al. Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2 receptors. 2008 J. Neurochem. pmid:18028337
Mizutani N et al. Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. 2007 J. Immunol. pmid:18025192
Moulin D et al. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. 2007 Cytokine pmid:18023358
Jongejan R et al. Effect of epithelial denudation, inflammatory mediators and mast cell activation on the sensitivity of isolated human airways to methacholine. 1991 Eur. J. Pharmacol. pmid:1800116
Song WL et al. Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans. 2008 J. Biol. Chem. pmid:17993463
Li SJ et al. [Effect of peroxisome proliferators-activated receptor gamma ligands on cytotrophoblast invasion in first trimester pregnancy]. 2007 Zhonghua Fu Chan Ke Za Zhi pmid:17983488
Lee JH et al. 15-deoxy-Delta 12,14-ProstaglandinJ2 regulates dedifferentiation through peroxisome proliferator-activated receptor-gamma-dependent pathway but not COX-2 expression in articular chondrocytes. 2007 J. Korean Med. Sci. pmid:17982241
Cao H et al. An improved LC-MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids. 2008 Anal. Biochem. pmid:17976507
Francis HP et al. BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig. 1991 Br. J. Pharmacol. pmid:1797323
Caito S et al. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, PPARgamma agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages. 2008 Antioxid. Redox Signal. pmid:17970647
Porter DW et al. PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages. 2007 J. Toxicol. Environ. Health Part A pmid:17966068
Jin YR et al. Antiplatelet effect of NQ12: a possible mechanism through the arachidonic acid cascade. 2007 J. Pharmacol. Sci. pmid:17951980
Yamauchi J et al. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts. 2007 Oct-Nov Prostaglandins Leukot. Essent. Fatty Acids pmid:17949962
Napimoga MH et al. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. 2008 J. Pharmacol. Exp. Ther. pmid:17928570
Yasui K et al. Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed to antigen. 2008 Eur. J. Pharmacol. pmid:17927976
Haack M et al. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. 2007 Sleep pmid:17910386
Poncin S et al. Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. 2008 Endocrinology pmid:17884933
Austen KF Doing what I like. 2008 Annu. Rev. Immunol. pmid:17877459
Kushikata T et al. [Sleep and anesthesia--Part 1, Recent findings in research]. 2007 Masui pmid:17877045
Brunoldi EM et al. Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione. 2007 Chem. Res. Toxicol. pmid:17854155
Shefler I et al. Inhibition of basic secretagogue-induced signaling in mast cells by cell permeable G alpha i-derived peptides. 2008 Int. Arch. Allergy Immunol. pmid:17848806
Kershaw EE et al. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. 2007 Am. J. Physiol. Endocrinol. Metab. pmid:17848638
Han H et al. 15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. 2007 Apoptosis pmid:17786557
Wang LH et al. Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. 2007 Blood pmid:17785586
Li W et al. Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture. 2008 Neurochem. Res. pmid:17763946
Wu P et al. Inflammation pro-resolving potential of 3,4-dihydroxyacetophenone through 15-deoxy-delta12,14-prostaglandin J2 in murine macrophages. 2007 Int. Immunopharmacol. pmid:17761349
Siddhivarn C et al. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line. 2007 J. Periodont. Res. pmid:17760815
Alvarez R et al. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin. 1991 Prostaglandins pmid:1775633
Chen Y et al. Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor. 2007 J. Immunol. pmid:17709490
Richard CL et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. 2007 Exp. Cell Res. pmid:17707368
Kondoh K et al. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. 2007 Exp. Cell Res. pmid:17706193
Iikura M et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. 2007 Lab. Invest. pmid:17700564
Saito Y et al. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. 2007 J. Neurochem. pmid:17697048
Li Y et al. Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. 2007 J. Am. Chem. Soc. pmid:17691773
Weiler H et al. Studies on the effects of aminopterin and methotrexate on the release of prostaglandin PGE2, PGD2, and PGI2 from small intestine in the rat in vivo. 1991 Clin. Chim. Acta pmid:1769112
Joo M et al. Induction and function of lipocalin prostaglandin D synthase in host immunity. 2007 J. Immunol. pmid:17675519
Fionda C et al. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. 2007 Mol. Pharmacol. pmid:17673570
Lin TH et al. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. 2007 Bone pmid:17669705
Olmos G et al. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. 2007 Cell. Signal. pmid:17658243
Ye Y et al. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2. 2007 Prostaglandins Other Lipid Mediat. pmid:17643887
Xiang Z et al. 15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells. 2007 J Neuroinflammation pmid:17634127
Lim HJ et al. 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells. 2007 Toxicol. Appl. Pharmacol. pmid:17631927
Pierzchalska M et al. Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics. 2007 J. Physiol. Pharmacol. pmid:17622692
Kaplan J et al. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells. 2007 Shock pmid:17621259
Nagai H [The role of lipid mediators in allergic diseases]. 2007 Arerugi pmid:17615500
Desmarais JA et al. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison). 2007 Biol. Reprod. pmid:17615406
Jung SM et al. Reduction of urate crystal-induced inflammation by root extracts from traditional oriental medicinal plants: elevation of prostaglandin D2 levels. 2007 Arthritis Res. Ther. pmid:17612394
Massey WA et al. Profile of prostanoid release following antigen challenge in vivo in the skin of man. 1991 Br. J. Dermatol. pmid:1760357
Zingarelli B et al. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt. 2007 Shock pmid:17589386
Wu L et al. Divergent effects of prostaglandin receptor signaling on neuronal survival. 2007 Neurosci. Lett. pmid:17574754
Saleem S et al. PGD(2) DP1 receptor protects brain from ischemia-reperfusion injury. 2007 Eur. J. Neurosci. pmid:17573924
Murakami M et al. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2. 1991 FEBS Lett. pmid:1756867
Hasegawa H et al. A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production. 2007 Blood pmid:17551094
Mendoza Magaña MJ et al. [Anaphylaxis and anaphylactic shock]. 2007 Mar-Apr Rev Alerg Mex pmid:17542244
Chiba T et al. Possible novel receptor for PGD2 on human bronchial epithelial cells. 2007 Int. Arch. Allergy Immunol. pmid:17541272
Ueki S et al. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions. 2007 Int. Arch. Allergy Immunol. pmid:17541271
Lin MS et al. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. 2007 J Dig Dis pmid:17532820
Engdahl R et al. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter. 2007 Biochem. Biophys. Res. Commun. pmid:17532302
Futaki N et al. Role of prostaglandins on mechanical scratching-induced cutaneous barrier disruption in mice. 2007 Exp. Dermatol. pmid:17518991
Monroy MA et al. THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model. 2007 Shock pmid:17510607
Wang XS et al. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease. 2007 Allergy pmid:17508965
Aschenbach JR et al. Functional characteristics of the porcine colonic epithelium following transportation stress and Salmonella infection. 2007 Scand. J. Gastroenterol. pmid:17505993
Renedo M et al. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. 2007 Biochemistry pmid:17489560
Ponferrada A et al. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. 2007 Gastroenterology pmid:17484875
Zhang XC et al. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. 2007 J. Pharmacol. Exp. Ther. pmid:17483291
Mazid MA et al. Development of enzyme-linked immunosorbent assay for prostaglandin D2 using the stable isosteric analogue as a hapten mimic and its application. 2007 Prostaglandins Other Lipid Mediat. pmid:17481559
Yano M et al. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. 2007 Circ. Res. pmid:17463321
Cerbone A et al. 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells. 2007 Free Radic. Biol. Med. pmid:17462534
Berry A et al. IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. 2007 Eur. J. Immunol. pmid:17458857
Zhao X et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. 2007 Ann. Neurol. pmid:17457822
Schütz TC et al. Effects of COX-2 inhibitor in temporomandibular joint acute inflammation. 2007 J. Dent. Res. pmid:17452571
Richman JG et al. Nicotinic acid receptor agonists differentially activate downstream effectors. 2007 J. Biol. Chem. pmid:17452318